ブルーサトールによるFOXM1/シスタチオニン-β-シンタゼ軸をターゲットにすることは,肺がんの悪性進行を抑制する

Yutong Wu¹, Haipeng Feng^2,3, Yichuan Wang³

¹Department of Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.

Phytotherapy research : PTR

|February 20, 2026

まとめ

ブルーサトールは天然の化合物で,FOXM1を直接標的にして分解し,肺がんの進行を抑制します. これはFOXM1/CBSシグナル伝達経路をブロックし,肺がんに対する新しい治療戦略を提供します.

科学分野:

薬理学薬理学とは
分子生物学は分子生物学である.
腫瘍学腫瘍学

背景:

ブルーサトール (BRU) は,肺がんにおける抗腫瘍の可能性を示しています.
肺がんにおける分子標的とメカニズムについては,さらなる調査が必要である.

研究の目的:

肺がんにおけるブルーサトールの分子標的とメカニズムを解明する.
ブルーサトールのFOXM1との相互作用とその下流効果を調査する.

主な方法:

ラベルなしの定量プロテオミック分析.
細胞増殖,アポトーシス,および細胞毒性アッセイ (コロニー形成,PI染色,CCK8)
ウェスタン・ブロット,qRT-PCR,SAベースのプルダウン,CTSA,分子ドッキング.

主要な成果:

ブルーサトールはFOXM1と直接相互作用し,その分解を引き起こし,肺がんの進行を抑制します.
FOXM1は,肺がんにおけるシスタチオニンベータ合成酵素 (CBS) の発現を強化する.
ブルーサトールは,FOXM1/CBSシグナル伝達軸をインビトロ,インビボ,患者由来オーガノイドで抑制する.

結論:

ブルーサトールは新しいFOXM1阻害剤として作用します.
ブルーサトールによるFOXM1/CBS軸の阻害は,肺がんに対する潜在的な治療戦略を示しています.

キーワード:

さらに関連する動画

08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

114.0K

13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K

関連する概念動画

02:57

Targeted Cancer Therapies

9.0K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

9.0K

01:23

Cystic Fibrosis: Pathogenesis

932

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

932

01:24

Cystic Fibrosis: Management

559

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

559

02:23

Abnormal Proliferation

5.3K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...